Roberto Carrió
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- interferon and immune responses
- Cancer Research top 10%
- NF-κB Signaling Pathways
Papers in
- Immunology 17
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 8
- Immune cells in cancer 3
-
- Cell death mechanisms and regulation 4
- Co-authors
- Jesús Merino (9 shared papers)Gabriel Núñez (6 shared papers)Thomas R. Malek (4 shared papers)Naohiro Inohara (4 shared papers)Shu Chen (4 shared papers)Takeyoshi Koseki (3 shared papers)Yuanming Hu (2 shared papers)Haoli Jin (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)Frontiers in Physiology (2 papers)Cancer Research (2 papers)Immunologic Research (2 papers)International Journal of Molecular Medicine (2 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Roberto Carrió
27 papers receiving 1.8k citations
Roberto Carrió's Hit Papers
Peers
Comparison fields: 5 of 88
- Immunology 1.1k
- Cancer Research 234
- Oncology 307
- Microbiology 71
- Molecular Biology 782
Countries citing papers authored by Roberto Carrió
This map shows the geographic impact of Roberto Carrió's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Carrió with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Carrió more than expected).
Fields of papers citing papers by Roberto Carrió
This network shows the impact of papers produced by Roberto Carrió. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Carrió. The network helps show where Roberto Carrió may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Carrió, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB Hit paper breakdown → | 1999 | 604 |
| 2 | 2004 | 223 | |
| 3 | 1998 | 143 | |
| 4 | 1999 | 128 | |
| 5 | 1998 | 105 | |
| 6 | 2011 | 100 | |
| 7 | 2004 | 88 | |
| 8 | 2015 | 84 | |
| 9 | 2014 | 57 | |
| 10 | 2007 | 36 | |
| 11 | A1 demonstrates restricted tissue distribution during embryonic development and functions to protect against cell death. | 1996 | 34 |
| 12 | 1996 | 32 | |
| 13 | 2013 | 29 | |
| 14 | 1999 | 27 | |
| 15 | 2013 | 24 | |
| 16 | 2008 | 23 | |
| 17 | 1998 | 21 | |
| 18 | 2009 | 18 | |
| 19 | 2013 | 17 | |
| 20 | 2012 | 14 |
About Roberto Carrió
Roberto Carrió is a scholar working on Immunology, Molecular Biology, Oncology, Epidemiology and Physiology, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (8 papers), Cell death mechanisms and regulation (4 papers), Immune cells in cancer (3 papers), CAR-T cell therapy research (3 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Immunology (1.1k citations), Cancer Research (234 citations), Oncology (307 citations), Microbiology (71 citations) and Molecular Biology (782 citations). Roberto Carrió has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Jesús Merino, Gabriel Núñez, Thomas R. Malek, Naohiro Inohara, Shu Chen, Takeyoshi Koseki, Yuanming Hu, Haoli Jin, Aixin Yu and Christina Yee. Their work appears in journals such as Journal of Biological Chemistry, Frontiers in Physiology, Cancer Research, Immunologic Research and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.